Skip to content

In the BioHarmony Drug Report Database

Zonisamide

Zonegran (zonisamide) is a small molecule pharmaceutical. Zonisamide was first approved as Zonegran on 2000-03-27. It is used to treat epilepsy and partial epilepsies in the USA. It has been approved in Europe to treat epilepsy and partial epilepsies. It is known to target carbonic anhydrase 7, carbonic anhydrase 12, and carbonic anhydrase 1.
Trade Name Zonegran
Common Name Zonisamide
Indication epilepsy, partial epilepsies
Drug Class
Zonisamide
Get full access now